The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACCURAY INC | COM | 004397105 | 2,265 | 300,000 | SH | SOLE | 0 | 300,000 | 0 | 0 | |
ACHILLION PHARMACEUTICALS IN | COM | 00448Q201 | 1,838 | 150,000 | SH | Call | SOLE | 0 | 150,000 | 0 | 0 |
ACTAVIS PLC | SHS | G0083B108 | 4,505 | 17,500 | SH | SOLE | 0 | 17,500 | 0 | 0 | |
ADVAXIS INC | COM | 007624208 | 3,389 | 423,100 | SH | SOLE | 0 | 423,100 | 0 | 0 | |
AIR METHODS CORP | COM PAR $.06 | 009128307 | 3,743 | 85,000 | SH | SOLE | 0 | 85,000 | 0 | 0 | |
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 5,335 | 55,000 | SH | SOLE | 0 | 55,000 | 0 | 0 | |
AMAG PHARMACEUTICALS INC | COM | 00163U106 | 3,410 | 80,000 | SH | SOLE | 0 | 80,000 | 0 | 0 | |
AMICUS THERAPEUTICS INC | COM | 03152W109 | 2,496 | 300,000 | SH | SOLE | 0 | 300,000 | 0 | 0 | |
ARIAD PHARMACEUTICALS INC | COM | 04033A100 | 2,061 | 300,000 | SH | SOLE | 0 | 300,000 | 0 | 0 | |
ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 511 | 65,000 | SH | SOLE | 0 | 65,000 | 0 | 0 | |
ATRICURE INC | COM | 04963C209 | 1,996 | 100,000 | SH | SOLE | 0 | 100,000 | 0 | 0 | |
AUSPEX PHARMACEUTICALS INC | COM | 05211J102 | 1,050 | 20,000 | SH | SOLE | 0 | 20,000 | 0 | 0 | |
AVALANCHE BIOTECHNOLOGIES IN | COM | 05337G107 | 6,750 | 125,000 | SH | SOLE | 0 | 125,000 | 0 | 0 | |
BELLICUM PHARMACEUTICALS INC | COM | 079481107 | 1,728 | 75,000 | SH | SOLE | 0 | 75,000 | 0 | 0 | |
BIODELIVERY SCIENCES INTL IN | COM | 09060J106 | 2,104 | 175,000 | SH | SOLE | 0 | 175,000 | 0 | 0 | |
BIOLASE INC | COM | 090911108 | 789 | 300,000 | SH | SOLE | 0 | 300,000 | 0 | 0 | |
BLUEBIRD BIO INC | COM | 09609G100 | 2,752 | 30,000 | SH | SOLE | 0 | 30,000 | 0 | 0 | |
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 3,616 | 40,000 | SH | SOLE | 0 | 40,000 | 0 | 0 | |
CATALYST PHARM PARTNERS INC | COM | 14888U101 | 743 | 250,000 | SH | SOLE | 0 | 250,000 | 0 | 0 | |
CELLADON CORP | COM | 15117E107 | 781 | 40,000 | SH | SOLE | 0 | 40,000 | 0 | 0 | |
CEPHEID | COM | 15670R107 | 5,414 | 100,000 | SH | SOLE | O | 100,000 | 0 | 0 | |
DBV TECHNOLOGIES S A | SPONSORED ADR | 23306J101 | 2,170 | 80,000 | SH | SOLE | 0 | 80,000 | 0 | 0 | |
DEPOMED INC | COM | 249908104 | 4,833 | 300,000 | SH | SOLE | 0 | 300,000 | 0 | 0 | |
DYAX CORP | COM | 26746E103 | 4,570 | 325,000 | SH | SOLE | 0 | 325,000 | 0 | 0 | |
FLAMEL TECHNOLOGIES SA | SPONSORED ADR | 338488109 | 5,567 | 325,000 | SH | SOLE | 0 | 325,000 | 0 | 0 | |
GILEAD SCIENCES INC | COM | 375558103 | 11,783 | 125,000 | SH | Call | SOLE | 0 | 125,000 | 0 | 0 |
GILEAD SCIENCES INC | COM | 375558103 | 6,127 | 65,000 | SH | SOLE | 0 | 65,000 | 0 | 0 | |
GLOBEIMMUNE INC | COM | 37957B100 | 178 | 23,500 | SH | SOLE | O | 23,500 | 0 | 0 | |
HORIZON PHARMA PLC | SHS | G4617B105 | 3,867 | 300,000 | SH | SOLE | 0 | 300,000 | 0 | 0 | |
IMMUNOGEN INC | CALL | 45253H901 | 1,830 | 300,000 | SH | SOLE | 0 | 300,000 | 0 | 0 | |
INSYS THERAPEUTICS INC NEW | COM NEW | 45824V209 | 4,216 | 100,000 | SH | SOLE | 0 | 100,000 | 0 | 0 | |
INTUITIVE SURGICAL INC | COM NEW | 46120E602 | 2,116 | 4,000 | SH | SOLE | 0 | 4,000 | 0 | 0 | |
ISIS PHARMACEUTICALS INC | COM | 464330109 | 9,261 | 150,000 | SH | Call | SOLE | 0 | 150,000 | 0 | 0 |
ISIS PHARMACEUTICALS INC | COM | 464330109 | 3,087 | 50,000 | SH | Put | SOLE | 0 | 50,000 | 0 | 0 |
KITE PHARMA INC | COM | 49803L109 | 3,460 | 60,000 | SH | SOLE | 0 | 60,000 | 0 | 0 | |
LA JOLLA PHARMACEUTICAL CO | COM PAR $.0001 2 | 503459604 | 5,278 | 286,053 | SH | SOLE | 0 | 286,053 | 0 | 0 | |
MERIT MED SYS INC | COM | 589889104 | 1,300 | 75,000 | SH | SOLE | 0 | 75,000 | 0 | 0 | |
NANOSTRING TECHNOLOGIES INC | COM | 63009R109 | 1,254 | 90,000 | SH | SOLE | 0 | 90,000 | 0 | 0 | |
NEVRO CORP | COM | 64157F103 | 4,447 | 115,000 | SH | SOLE | 0 | 115,000 | 0 | 0 | |
NUVASIVE INC | COM | 670704105 | 4,244 | 90,000 | SH | SOLE | 0 | 90,000 | 0 | 0 | |
OCERA THERAPEUTICS INC | COM | 67552A108 | 796 | 125,000 | SH | SOLE | 0 | 125,000 | 0 | 0 | |
OPHTHOTECH CORP | COM | 683745103 | 2,917 | 65,000 | SH | SOLE | 0 | 65,000 | 0 | 0 | |
PORTOLA PHARMACEUTICALS INC | COM | 737010108 | 4,248 | 150,000 | SH | SOLE | 0 | 150,000 | 0 | 0 | |
PTC THERAPEUTICS INC | COM | 69366J200 | 4,400 | 85,000 | SH | SOLE | 0 | 85,000 | 0 | 0 | |
PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 5,678 | 30,000 | SH | SOLE | 0 | 30,000 | 0 | 0 | |
QUIDEL CORP | COM | 74838J101 | 2,892 | 100,000 | SH | SOLE | 0 | 100,000 | 0 | 0 | |
RAPTOR PHARMACEUTICAL CORP | COM | 75382F106 | 1,578 | 150,000 | SH | SOLE | 0 | 150,000 | 0 | 0 | |
SALIX PHARMACEUTICALS INC | COM | 795435106 | 3,448 | 30,000 | SH | SOLE | 0 | 30,000 | 0 | 0 | |
SMITH & NEPHEW PLC | SPDN ADR NEW | 83175M205 | 1,102 | 30,000 | SH | SOLE | 0 | 30,000 | 0 | 0 | |
STRYKER CORP | COM | 863667101 | 9,433 | 100,000 | SH | Call | SOLE | 0 | 100,000 | 0 | 0 |
STRYKER CORP | COM | 863667101 | 3,302 | 35,000 | SH | SOLE | 0 | 35,000 | 0 | 0 | |
TANDEM DIABETES CARE INC | COM | 875372104 | 1,270 | 100,000 | SH | SOLE | 0 | 100,000 | 0 | 0 | |
THERAPEUTICSMD INC | COM | 88338N107 | 2,834 | 636,800 | SH | SOLE | 0 | 636,800 | 0 | 0 | |
UNIVERSAL HLTH SVCS INC | CL B | 913903100 | 3,338 | 30,000 | SH | SOLE | 0 | 30,000 | 0 | 0 | |
VALEANT PHARMACEUTICALS INTL | COM | 91911K102 | 2,862 | 20,000 | SH | SOLE | 0 | 20,000 | 0 | 0 | |
WRIGHT MED GROUP INC | COM | 98235T107 | 6,314 | 235,000 | SH | SOLE | 0 | 235,000 | 0 | 0 | |
WRIGHT MED GROUP INC | RIGHT 03/01/2019 | 98235T115 | 884 | 185,000 | SH | SOLE | 0 | 185,000 | 0 | 0 | |
ZELTIQ AESTHETICS INC | COM | 98933Q108 | 4,466 | 160,000 | SH | SOLE | 0 | 160,000 | 0 | 0 | |
ZIMMER HLDGS INC | COM | 98956P102 | 9,777 | 86,200 | SH | SOLE | 0 | 86,200 | 0 | 0 |